- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03575273
The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid Dependence
December 14, 2020 updated by: Johns Hopkins University
The Impact of Methadone Maintenance Therapy on Food Intake and Food Reward Processing in Opioid Dependence: An Event-related Brain Potential Study
Methadone maintenance therapy (MMT) has shown clear efficacy for relieving opioid withdrawal symptoms and reducing the morbidity and mortality of opioid dependence.
A notable phenomenon associated with MMT is increased food intake, enhanced sweet preferences, and weight gain.
The underlying neural mechanisms for opioid-related overconsumption are not well understood but are thought to arise from role in 1) increasing the palatability and hedonic aspects of food and 2) diminishing satiety signaling systems.
In the proposed project, the investigators will examine methadone's potential role in opioid-related overconsumption of food.
The investigators propose to examine eating behavior, sucrose preferences, and an event-related potential (ERP) component that is induced by appetitive motivation for highly rewarding foods in patients with a history of opioid dependence receiving methadone maintenance therapy (O+MMT) and not receiving opioid agonist therapy (O-MMT).
A matched sample of obese and overweight adults without history of opioid use (HOC) will also be examined.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Methadone maintenance therapy (MMT) has shown clear efficacy for relieving opioid withdrawal symptoms and reducing the morbidity and mortality of opioid dependence.
A notable phenomenon associated with MMT is increased food intake, enhanced sweet preferences, and weight gain.
The underlying neural mechanisms for opioid-related overconsumption are not well understood but are thought to arise from role in 1) increasing the palatability and hedonic aspects of food and 2) diminishing satiety signaling systems.
In the proposed project, the investigators will examine methadone's potential role in opioid-related overconsumption of food.
The investigators propose to examine eating behavior, sucrose preferences, and an event-related potential (ERP) component that is induced by appetitive motivation for highly rewarding foods in patients with a history of opioid dependence receiving methadone maintenance therapy (O+MMT) and not receiving opioid agonist therapy (O-MMT).
A matched sample of obese and overweight adults without history of opioid use (HOC) will also be examined.
Specifically, group differences in food intake and eating behaviors in the O+MMT group relative to individuals in the O-MMT and HOC group will be examined.
Individuals will complete 24-hour dietary food recalls and inventories to characterize eating behavior and food addiction.
Participants will complete psychophysical measures of chemosensory functioning of sucrose preference and pleasantness and identification ratings for odors varying in participants' hedonic characteristics.
Individuals will also complete validated computer tasks to assess food preferences.
Differences in cortical ERPs for high-reward food relative to low-reward food and non-food items will be examined.
Event-related potentials will be recorded as participants view photos of rewarding and non-rewarding food items, as well as non-food items.
ERP components that index sustained attentional engagement will be measured and compared.
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Johns Hopkins Hospital
-
Baltimore, Maryland, United States, 21205
- Broadway Center for Addictions
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion criteria:
- English-speaking individuals
- Must be between 18 and 60 years of age
- For the O+MMT group, participants must be receiving MMT for at least 3 months
- For the O-MMT group, participants must have concluded their MMT (if applicable) at least three months prior to the date of the screening visit.
Exclusion criteria:
- Individuals may not have a history of major neurological disorders
- No unstable medical issues that would affect appetite or blood glucose
- No pervasive developmental disorder or intellectual disability
- No significant visual/auditory impairment
- No history or current episode of psychosis
- No current opioid abuse
- No current antipsychotic medication use
- No major conditions that affect chemosensory function (e.g., history of nasal fracture or respiratory infection)
- Individuals with contraindication for the EEG will be excluded
- Individuals who are current pregnant or breastfeeding will not be enrolled
- For HOC, individuals with history of opioid dependence or current or past psychiatric disorders will be excluded
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Opioid dependence receiving methadone
Patients with a history of opioid dependence receiving methadone maintenance therapy will be administered Sniffin' Sticks Odor Identification and Hedonic Scale, Sucrose Taste Preference Assessment, Food Preferences Task, Progressive Ratio Task, Clinical Electrophysiology, and Standardized Meal and Hunger and Satiety Ratings
|
This task measures odor identification accuracy and perceived pleasantness of odors.
This task measures participant ratings of sucrose preference.
Participants rate images of various food stimuli.
Variables derived include relative preferences and reaction time (in milliseconds).
In the PR task, the subject is required to make an increasing number of operant responses for each successive reward
To examine motivated attention in response to food stimuli, brain electrophysiology via event related potentials (ERPs) will be assessed while participants view and rate images of food and non-food items.
Participants will receive a standardized meal and complete hunger and satiety ratings.
|
|
Experimental: Opioid dependence not on methadone
Patients with a history of opioid dependence not current receiving methadone maintenance therapy will be administered Sniffin' Sticks Odor Identification and Hedonic Scale, Sucrose Taste Preference Assessment, Food Preferences Task, Progressive Ratio Task, Clinical Electrophysiology, and Standardized Meal and Hunger and Satiety Ratings
|
This task measures odor identification accuracy and perceived pleasantness of odors.
This task measures participant ratings of sucrose preference.
Participants rate images of various food stimuli.
Variables derived include relative preferences and reaction time (in milliseconds).
In the PR task, the subject is required to make an increasing number of operant responses for each successive reward
To examine motivated attention in response to food stimuli, brain electrophysiology via event related potentials (ERPs) will be assessed while participants view and rate images of food and non-food items.
Participants will receive a standardized meal and complete hunger and satiety ratings.
|
|
Active Comparator: Healthy controls
Healthy controls without history of opioid use will be administered Sniffin' Sticks Odor Identification and Hedonic Scale, Sucrose Taste Preference Assessment, Food Preferences Task, Progressive Ratio Task, Clinical Electrophysiology, and Standardized Meal and Hunger and Satiety Ratings
|
This task measures odor identification accuracy and perceived pleasantness of odors.
This task measures participant ratings of sucrose preference.
Participants rate images of various food stimuli.
Variables derived include relative preferences and reaction time (in milliseconds).
In the PR task, the subject is required to make an increasing number of operant responses for each successive reward
To examine motivated attention in response to food stimuli, brain electrophysiology via event related potentials (ERPs) will be assessed while participants view and rate images of food and non-food items.
Participants will receive a standardized meal and complete hunger and satiety ratings.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Event-related potentials measured via BrainVision actiCHamp system
Time Frame: At baseline visit
|
Cortical ERPs for high-reward food relative to low-reward food and non-food items will be measured using a BrainVision actiCHamp system (32-channel amplifier).
For each group, the grand averages and standard deviations for the late positive potential will be calculated.
Group differences in LPP will be assessed within and between picture categories for each arm of the study.
|
At baseline visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Chemosensory Processing
Time Frame: At baseline visit
|
For the odorants, participants provide a rating of intensity and pleasantness based on a -5 to 5 point scale for each of the 16 markers.
Afterwards, averages of all 16 marker scores will be calculated for the mean ratings of intensity and pleasantness.
Odor identification accuracy will be assessed for each marker, with the score representing the total items correct out of 16.
|
At baseline visit
|
|
Food Preferences Task
Time Frame: At baseline visit
|
Participants are showed images of high fat savory, low fat savory, high fat sweet, and low fat sweet foods.
Participants must select one of the two pictures to answer the question "which food item do you most want to eat right now." Selection averages of each category and time for selection, for each arm of the study, are automatically calculated by E-Prime software.
|
At baseline visit
|
|
Progressive Ratio Task
Time Frame: At baseline visit
|
Participants begin with 20 M&Ms and a computer prompt that specifies how many times the mouse must be clicked to earn a piece of candy.
Participants can earn as little as desired.
The click ratio starts at 10 and geometrically increases in increments of 2 (i.e., 10, 20, 40, 80, etc.).
The computer program E-Prime automatically records the participant's work capacity and the administrator records the number of M&Ms left in the cup.
|
At baseline visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Vidya Kamath, Ph.D., Johns Hopkins University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 12, 2018
Primary Completion (Actual)
December 1, 2019
Study Completion (Actual)
June 1, 2020
Study Registration Dates
First Submitted
June 21, 2018
First Submitted That Met QC Criteria
June 29, 2018
First Posted (Actual)
July 2, 2018
Study Record Updates
Last Update Posted (Actual)
December 16, 2020
Last Update Submitted That Met QC Criteria
December 14, 2020
Last Verified
December 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00092798
- P30DK072488 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Sniffin' Sticks Odor Identification and Hedonic Scale
-
Sultan Abdulhamid Han Training and Research Hospital...Completed
-
Queen's UniversityProvidence HealthcareCompleted
-
Cliniques universitaires Saint-Luc- Université...RecruitingTelomere Shortening | Telomere DiseaseBelgium
-
University Medical Center GroningenCompleted
-
Rennes University HospitalInstitut NuMeCan, INRAE 1341Completed
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedNasal Polyps | Chronic Rhinosinusitis With Nasal Polyps | Olfaction DisordersFrance
-
Skane University HospitalLund UniversityRecruitingSynucleinopathies | Lewy Body Disease | Parkinson´s Disease | Synucleinopathy | REM Sleep Behavior Disorder (iRBD)Sweden
-
Mustafakemalpasa State HospitalCompletedAlcohol Drinking | Substance Use | Energy Drinks | University StudentsTurkey
-
Uppsala UniversityThe Kamprad Family Foundation for Entrepreneurship, Research & CharityRecruitingOpioid Use Disorder | Alcohol Use Disorder | Opioid Use | Pain, ChronicSweden